Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunogenic compositions for use in pneumococcal vaccines

Immunogenic compositions for use in pneumococcal vaccines

US Patent 11135279 · Granted Oct 5, 2021

Estimated economic value: $1,358,896,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Neisseria meningitidis compositions and methods thereof2025
Immunogenic compositions for use in pneumococcal vaccines2025
Immunogenic compositions for use in pneumococcal vaccines2025
Immunogenic compositions for use in pneumococcal vaccines2025
Compositions and methods relating to a mutant Clostridium difficile toxin2024
Immunogenic compositions comprising conjugated capsular saccharide antigens and 2024
Immunogenic compositions comprising conjugated capsular saccharide antigens and 2024
Immunogenic compositions comprising conjugated capsular saccharide antigens and 2024
Neisseria meningitidis compositions and methods thereof2023
Neisseria meningitidis compositions and methods thereof2023
Neisseria meningitidis compositions and methods thereof2023
Compositions relating to a mutant clostridium difficile toxin and methods thereo2022